Kuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law Firm
March 22, 2024 13:34 ET
|
KUEHN LAW, PLLC
Kuehn Law investigates potential claims related to proposed mergers of NGM, CTLT, SDPI, and HRT. Shareholders urged to contact for more info.
CTLT Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Catalent, Inc. for Potential Securities Law Violations
February 07, 2024 09:13 ET
|
Wohl & Fruchter LLP
MONSEY, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Catalent, Inc. (NYSE: CTLT) (“Catalent”) has violated federal securities laws based...
Kuehn Law Encourages ZFOX, CTLT, SLAM, and EVBG Investors to Contact Law Firm
February 06, 2024 11:13 ET
|
KUEHN LAW, PLLC
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
CTLT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Catalent to Novo Holdings
February 05, 2024 10:04 ET
|
Wohl & Fruchter LLP
We are investigating the fairness of the sale of Catalent to Novo Holdings for $63.50 per share in cash.
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 27, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE:...
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 21, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE:...
Regeneron Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
July 25, 2023 15:04 ET
|
Block & Leviton LLP
BOSTON, July 25, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) for potential securities law violations. Investors who have lost money...
Strong Growth Projected for Biologics CDMO Market with a CAGR of 11.8% during 2022-2032, Fueled by Technological Advancements in Bioprocessing - BY PMI
June 14, 2023 12:30 ET
|
PMI
Covina, June 14, 2023 (GLOBE NEWSWIRE) -- What is Biologics CDMO? How big is the Biologics CDMO Market? Report Overview: Biologics are group of medicines which includes, immune modulators,...
CTLT FINAL DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important April 25 Deadline in Securities Class Action – CTLT
April 22, 2023 12:35 ET
|
The Rosen Law Firm PA
NEW YORK, April 22, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. (NYSE: CTLT) between August 30, 2021 and...
CATALENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Catalent, Inc. and Encourages Investors to Contact the Firm
April 21, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed...